🧬 Over 16 Million Nigerians Living With Hepatitis B

Over 16 million Nigerians live with Hepatitis B. Lagos State begins free screening and vaccination campaign to tackle the silent epidemic head-on.

🧬 Over 16 Million Nigerians Living With Hepatitis B

In a major public health intervention, the Lagos State Government has launched free testing and limited vaccination for Hepatitis B and C across the state, revealing that over 16 million Nigerians are currently living with Hepatitis B and over 2 million with Hepatitis C.

The campaign comes as part of the state’s strategic response to the 2025 World Hepatitis Day under the theme ā€œHepatitis: Let’s Break It Down.ā€


🧠 Hepatitis: The Silent Epidemic

Speaking at a press briefing in Alausa, Commissioner for Health Prof. Akin Abayomi described viral hepatitis as a ā€œsilent but deadly diseaseā€ and urged residents to get tested and vaccinated early.

ā€œIt causes liver damage, cirrhosis, and cancer — often without symptoms. Yet it’s preventable, treatable, and in some cases, curable,ā€ Abayomi said.


šŸ’‰ What Lagos Is Offering

  • Free testing for Hepatitis B and C across all general hospitals, LASUTH, and designated PHCs in all 57 LGAs and LCDAs.

  • Limited free vaccination, prioritising pregnant women and healthcare workers.

  • Public awareness campaign via radio, TV, and social media.


šŸ‘¶ Prevention From Birth

Abayomi noted that vaccination against Hepatitis B is now integrated into routine newborn immunisation, while all pregnant women are being screened during antenatal care to prevent mother-to-child transmission.

ā€œWe aim to demystify hepatitis through testing, prevention, treatment, and awareness — all four are key to eliminating it by 2030,ā€ he said.


This is IDNN. Independent. Digital. Uncompromising.

Related posts

Victor Osimhen Faces Surgery After Fractured Arm in Galatasaray’s Loss to Liverpool

Medical Negligence Suit Filed Over Death of Chimamanda Adichie’s Son

Health Ministry Orders Immediate Retirement of Long-Serving Directors

This website uses cookies to improve User experience. Learn More